Literature DB >> 27671729

Integrated Approaches to Testing and Assessment.

Andrew P Worth1, Grace Patlewicz2,3.   

Abstract

In this chapter, we explain how Integrated Approaches to Testing and Assessment (IATA) offer a means of integrating and translating the data generated by toxicity testing methods, thereby serving as flexible and suitable tools for toxicological decision making in the twenty-first century. In addition to traditional in vitro and in vivo testing methods, IATA are increasingly incorporating newly developed in vitro systems and measurement technologies such as high throughput screening and high content imaging. Computational approaches are also being used in IATA development, both as a means of generating data (e.g. QSARs), interpreting data (bioinformatics and chemoinformatics), and as a means of integrating multiple sources of data (e.g. expert systems, bayesian models). Decision analytic methods derived from socioeconomic theory can also play a role in developing flexible and optimal IATA solutions. Some of the challenges involved in the development, validation and implementation of IATA are also discussed.

Entities:  

Keywords:  Adverse outcome pathway; Chemical safety assessment; Integrated approach to testing and assessment (IATA); Integrated testing strategy (ITS); Predictive toxicology

Mesh:

Year:  2016        PMID: 27671729     DOI: 10.1007/978-3-319-33826-2_13

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  4 in total

1.  Adverse outcome pathway networks II: Network analytics.

Authors:  Daniel L Villeneuve; Michelle M Angrish; Marie C Fortin; Ioanna Katsiadaki; Marc Leonard; Luigi Margiotta-Casaluci; Sharon Munn; Jason M O'Brien; Nathan L Pollesch; L Cody Smith; Xiaowei Zhang; Dries Knapen
Journal:  Environ Toxicol Chem       Date:  2018-05-07       Impact factor: 3.742

2.  High-Content Assay Multiplexing for Muscle Toxicity Screening in Human-Induced Pluripotent Stem Cell-Derived Skeletal Myoblasts.

Authors:  William D Klaren; Ivan Rusyn
Journal:  Assay Drug Dev Technol       Date:  2018-08-02       Impact factor: 1.738

Review 3.  Adverse outcome pathways: Application to enhance mechanistic understanding of neurotoxicity.

Authors:  Anna Bal-Price; M E Bette Meek
Journal:  Pharmacol Ther       Date:  2017-05-18       Impact factor: 12.310

Review 4.  Nonclinical regulatory immunotoxicity testing of nanomedicinal products: Proposed strategy and possible pitfalls.

Authors:  Christina Giannakou; Margriet V D Z Park; Irene E M Bosselaers; Wim H de Jong; Jan Willem van der Laan; Henk van Loveren; Rob J Vandebriel; Robert E Geertsma
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2020-04-07
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.